- Home
- MSDL vs LMAT Comparison
MSDL vs LMAT Comparison
Compare MSDL & LMAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MSDL
- LMAT
- Stock Information
- Founded
- MSDL 2019
- LMAT 1983
- Country
- MSDL United States
- LMAT United States
- Employees
- MSDL N/A
- LMAT N/A
- Industry
- MSDL
- LMAT Medical/Dental Instruments
- Sector
- MSDL
- LMAT Health Care
- Exchange
- MSDL NYSE
- LMAT Nasdaq
- Market Cap
- MSDL N/A
- LMAT 1.9B
- IPO Year
- MSDL N/A
- LMAT 2006
- Fundamental
- Price
- MSDL $19.26
- LMAT $81.50
- Analyst Decision
- MSDL Hold
- LMAT Buy
- Analyst Count
- MSDL 6
- LMAT 7
- Target Price
- MSDL $20.20
- LMAT $100.67
- AVG Volume (30 Days)
- MSDL 414.9K
- LMAT 188.6K
- Earning Date
- MSDL 01-01-0001
- LMAT 05-01-2025
- Dividend Yield
- MSDL 10.38%
- LMAT 0.97%
- EPS Growth
- MSDL N/A
- LMAT 30.45
- EPS
- MSDL N/A
- LMAT 1.97
- Revenue
- MSDL N/A
- LMAT $226,256,000.00
- Revenue This Year
- MSDL $1,597.39
- LMAT $11.00
- Revenue Next Year
- MSDL $15.10
- LMAT $8.48
- P/E Ratio
- MSDL N/A
- LMAT $41.43
- Revenue Growth
- MSDL N/A
- LMAT 13.19
- 52 Week Low
- MSDL $17.59
- LMAT $71.42
- 52 Week High
- MSDL $24.18
- LMAT $109.58
- Technical
- Relative Strength Index (RSI)
- MSDL 47.67
- LMAT 42.02
- Support Level
- MSDL $19.02
- LMAT $78.01
- Resistance Level
- MSDL $19.66
- LMAT $83.51
- Average True Range (ATR)
- MSDL 0.35
- LMAT 3.22
- MACD
- MSDL 0.04
- LMAT -0.83
- Stochastic Oscillator
- MSDL 33.64
- LMAT 23.07
About LMAT LeMaitre Vascular Inc.
LeMaitre Vascular Inc manufactures and distributes medical devices for the treatment of peripheral vascular disease. Its products are used during open vascular surgery and address several anatomical areas, such as the carotid, lower extremities, upper extremities, and aorta. The firm's lower extremities product line contributes towards the proportion of revenue, followed by the carotid product line. LeMaitre's surgical devices include angioscopes, balloon catheters, carotid shunts, phlebectomy devices, vascular grafts, vascular patches, and vessel closure systems. LeMaitre generates the majority of its revenue in the United States.